External resources SURMOUNT-5 Trial: Tirzepatide vs Semaglutide for Obesity (New England Journal of Medicine) SURPASS-2 Trial: Tirzepatide vs Semaglutide for Type 2 Diabetes (New England Journal of Medicine) Tirzepatide Dual GIP/GLP-1 Receptor Agonist Mechanism (JCI Insight) Why Weight Loss Drugs Do Not Work for Everyone: Genetics (Scientific American) Factors Associated with Weight Loss Response to GLP-1 Analogues (PMC) In case I do not see you, good afternoon, good evening, and good night
The guidance makes clear that diagnosing the patient and deciding on the mode of treatment cannot be delegated or performed by nurses or medical assistants
Contemporary GLP-1 receptor agonists are produced through sophisticated biotechnology and pharmaceutical manufacturing processes , not by extracting venom from lizards
If you receive a Wegovy pen and the liquid inside appears cloudy, tinted, or contains any visible particles, do not use it
Chen H, Lu Y, Shi S, Zhang Q, Cao X et al (2022) Design and development of a new glucagon-like peptide-1 receptor agonist to obtain high oral bioavailability